| Literature DB >> 31936867 |
Hye-Yoon Lee1, Sung Hun Choi2, Jae Suk Rim3, Ho-Kyung Lim3, Young Soo Heo4, Jeonghee Shin5, Rinet Aieng6, Chai Hong Rim7.
Abstract
Background andEntities:
Keywords: Cambodia; hypertension; medical volunteering
Year: 2020 PMID: 31936867 PMCID: PMC7023312 DOI: 10.3390/medicina56010030
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Anthropometric characteristics of patients.
| Patient Characteristics | Females ( | Males ( | Children ( |
|---|---|---|---|
| Age | 53.5 (19–87) | 53.5 (19–87) | 10 (0.5–17) |
| Weight (kg) | 52.1 (30.9–77.9) | 57.4 (37.6–89.0) | 23.6 (3.4–72.5) |
| Height (m) | 1.54 (1.35–1.74) | 1.65 (1.47–1.80) | |
| BMI | 22.0 (14.4–33.5) | 21.5 (14.9–29.5) |
BMI—body mass index; Data are presented as median (range).
Hypertension according to BMI, age, and gender.
| Patient Characteristics | No HTN ( | Grade 1 ( | Grade 2 ( | |
|---|---|---|---|---|
| mean (95% confidence interval) | ||||
| BMI | 21.7 (21.2–22.2) | 22.8 (21.9–23.7) | 22.9 (21.5–24.3) | 0.003 † |
| Age | 49.7 (47.6–51.7) | 55.5 (52.0–59.1) | 58.7 (52.9–64.4) | <0.001 † |
| percentile among patients | ||||
| Females ( | 70.6% | 21.8% | 7.6% | |
| Males ( | 61.6% | 22.7% | 13.1% | 0.069 ‡ |
BMI—body mass index; HTN—hypertension. † Jonckheere-Terpstra test. ‡ Linear-by-linear association.
Primary diagnosis categorized by chronicity of chief complaints.
| Duration of Chief Complaints | |||
|---|---|---|---|
| Acute (≤1 month, 46 Cases) | Subchronic (1–6 months, 44 Cases) | Chronic (>6 months, 143 Cases) | (N/A 84 Cases) |
|
| |||
| common cold (17.4%) | musculoarthritis (31.8%) | musculoarthritis (31.5%) | |
| musculoarthritis (17.4%) | GERD and/or gastritis (25.0%) | GERD and/or gastritis (21.7%) | |
| GERD and/or gastritis (13.0%) | cystitis and/or vaginitis (15.3%, female) | HTN and/or cardiac problem (13.6%, male) | |
|
| |||
| (≤1 month, 84 cases) | (longer than 1 month, 20 cases) | ||
| common cold (54.8%) | sustained URI (20.0%) | ||
| GERD and/or gastritis (8.3%) | GERD and/or gastritis (15.0%) | ||
| rhinitis (7.1%) | |||
| pneumonitis (6.0%) | |||
GERD—gastroesophageal reflux disease; HTN—hypertension; N/A—not applicable; URI—upper respiratory infection.
Common illnesses categorized by severities (including primary and secondary diagnoses).
| Severity of Illnesses | |||
|---|---|---|---|
| Short-Term Care Needed | Long-Term Care Needed | Specialized or Intensive Care Recommended | |
|
| |||
| (200 cases, 282 diagnoses) | (52 cases, 70 diagnoses) | (45 cases, 61 diagnoses) | (N/A 20 cases) |
| GERD and/or gastritis (26.9%) | musculoarthritis (37.1%) | cardiac illness (14.8%) | |
| musculoarthritis (25.9%) | hypertension (14.3%) | musculoarthritis (13.1%) | |
| headache (9.2%) | GERD and/or gastritis (12.9%) | GERD and/or gastritis (11.5%) | |
| common cold/URI (5.3%) | pneumonitis and/or COPD (11.4%) | thyroid nodule (8.2%) | |
| cystitis (4.6%) | rule out Meniere’s or BPPV (8.2%) | ||
| dermatitis (3.2%) | psychologic disorder (6.6%) | ||
|
| |||
| (115 cases, 122 diagnoses) | (4 cases, 4 diagnoses) | (8 cases, 9 diagnoses) | (N/A 14 cases) |
| common cold (45.1%) | malnutrition (75%) | otitis and/or tonsillitis (55.6%) | |
| GERD and/or gastritis (9.0%) | pneumonitis (22.9%) | ||
| headache (6.6%) | |||
| dermatitis (5.7%) | |||
| rhinitis (5.7%) | |||
BPPV—benign paroxysmal postural vertigo; COPD—chronic obstructive pulmonary disease; GERD—gastroesophageal reflux disease; N/A—not applicable; URI—upper respiratory infection.
Commonly prescribed medications.
| Type of Medications | Prescription Cases | (%) |
|---|---|---|
|
| ||
| Antacids or GI mucosal protectors | 232 | 31.3% |
| NSAIDs/painkiller | 205 | 27.6% |
| Antiparasites | 131 | 17.7% |
| Anticough or mucolytics | 53 | 7.1% |
| Antibiotics | 36 | 4.9% |
| Others | 353 | 11.5% |
| 742 | ||
|
| ||
| NSAIDs | 85 | 44.7% |
| Antiparasites | 44 | 23.2% |
| Electrolyte supplements | 13 | 6.8% |
| Antibiotics | 11 | 5.8% |
| Antacids or GI protectors | 10 | 5.3% |
| Others | 27 | 14.2% |
| All prescription cases | 190 |
GI—gastrointestinal; NSAID—nonsteroidal anti-inflammatory drugs.